Company Filing History:
Years Active: 2018-2023
Title: Wouter Frank Tonnis: Pioneering Innovations in Vaccine Development
Introduction
Wouter Frank Tonnis is a notable inventor based in Berlin, Germany, with a remarkable portfolio of six patents. His contributions to the field of immunology and vaccine formulation are noteworthy, embodying advancements that have the potential to impact public health significantly.
Latest Patents
Tonnis’s latest patents focus on cutting-edge developments in vaccine formulations. One of his key innovations is the ExPEC glycoconjugate vaccine, which describes compositions and methods designed to induce an immune response against extra-intestinal pathogenic E. coli. Notably, this multivalent vaccine includes O-antigen polysaccharide covalently bound to an exotoxin A carrier protein, capable of withstanding various environmental stresses. Another significant patent involves a stable virus-containing composition, detailing formulations that comprise enveloped viruses, a sulfate salt concentration ranging from 5 mM to about 300 mM, and a buffer maintaining a pH between 6.0 and 8.5. This patent also outlines methods for stabilizing such viral compositions.
Career Highlights
Throughout his career, Wouter Frank Tonnis has made impactful contributions to the pharmaceutical and vaccine sectors, working at reputable companies such as Janssen Pharmaceuticals, Inc. and Janssen Vaccines & Prevention B.V. His experience in these organizations has allowed him to push the boundaries of research and development in vaccine technology.
Collaborations
Tonnis has collaborated with esteemed professionals in his field, including Olga Labovitiadi and Francesco Doro. These partnerships have facilitated the exchange of ideas and innovation, contributing to Tonnis's success as an inventor.
Conclusion
Wouter Frank Tonnis exemplifies the spirit of innovation and dedication in the pursuit of advancements in medical science. With a focus on developing effective vaccines, his work continues to pave the way for significant breakthroughs in immunology and public health. His contributions not only showcase his inventiveness but also highlight the importance of collaboration in achieving successful outcomes in research and development.